These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular-receptor-specific, non-toxic, near-infrared-emitting Au cluster-protein nanoconjugates for targeted cancer imaging. Retnakumari A, Setua S, Menon D, Ravindran P, Muhammed H, Pradeep T, Nair S, Koyakutty M. Nanotechnology; 2010 Feb 05; 21(5):055103. PubMed ID: 20023317 [Abstract] [Full Text] [Related]
3. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer. Saxena V, Naguib Y, Hussain MD. Colloids Surf B Biointerfaces; 2012 Jun 01; 94():274-80. PubMed ID: 22377218 [Abstract] [Full Text] [Related]
4. PLGA/polymeric liposome for targeted drug and gene co-delivery. Wang H, Zhao P, Su W, Wang S, Liao Z, Niu R, Chang J. Biomaterials; 2010 Nov 01; 31(33):8741-8. PubMed ID: 20727587 [Abstract] [Full Text] [Related]
5. A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent. Ashokan A, Menon D, Nair S, Koyakutty M. Biomaterials; 2010 Mar 01; 31(9):2606-16. PubMed ID: 20035998 [Abstract] [Full Text] [Related]
6. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies. Zheng Y, Cai Z, Song X, Chen Q, Bi Y, Li Y, Hou S. J Drug Target; 2009 May 01; 17(4):294-303. PubMed ID: 19255895 [Abstract] [Full Text] [Related]
7. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery. Guo M, Que C, Wang C, Liu X, Yan H, Liu K. Biomaterials; 2011 Jan 01; 32(1):185-94. PubMed ID: 21067808 [Abstract] [Full Text] [Related]
8. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles. Schroeder JE, Shweky I, Shmeeda H, Banin U, Gabizon A. J Control Release; 2007 Dec 04; 124(1-2):28-34. PubMed ID: 17928088 [Abstract] [Full Text] [Related]
9. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Acharya S, Dilnawaz F, Sahoo SK. Biomaterials; 2009 Oct 04; 30(29):5737-50. PubMed ID: 19631377 [Abstract] [Full Text] [Related]
10. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles. Niu X, Zou W, Liu C, Zhang N, Fu C. Drug Dev Ind Pharm; 2009 Nov 04; 35(11):1375-83. PubMed ID: 19832638 [Abstract] [Full Text] [Related]
11. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes. Chiu SJ, Marcucci G, Lee RJ. Anticancer Res; 2006 Nov 04; 26(2A):1049-56. PubMed ID: 16619505 [Abstract] [Full Text] [Related]
12. Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery. Wang H, Zhao P, Liang X, Gong X, Song T, Niu R, Chang J. Biomaterials; 2010 May 04; 31(14):4129-38. PubMed ID: 20163853 [Abstract] [Full Text] [Related]
13. Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy. Thamake SI, Raut SL, Ranjan AP, Gryczynski Z, Vishwanatha JK. Nanotechnology; 2011 Jan 21; 22(3):035101. PubMed ID: 21149963 [Abstract] [Full Text] [Related]
14. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery. Xin Y, Liu T, Yang C. Int J Nanomedicine; 2016 Jan 21; 11():5807-5821. PubMed ID: 27853366 [Abstract] [Full Text] [Related]
15. Targeted folic acid-PEG nanoparticles for noninvasive imaging of folate receptor by MRI. Chen TJ, Cheng TH, Hung YC, Lin KT, Liu GC, Wang YM. J Biomed Mater Res A; 2008 Oct 21; 87(1):165-75. PubMed ID: 18085650 [Abstract] [Full Text] [Related]
16. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Kim SH, Jeong JH, Chun KW, Park TG. Langmuir; 2005 Sep 13; 21(19):8852-7. PubMed ID: 16142970 [Abstract] [Full Text] [Related]
17. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V, Denora N, Lopalco A, Lopedota A, Cutrignelli A, Lasorsa FM, Agostino G, Franco M. Mol Pharm; 2014 Mar 03; 11(3):859-71. PubMed ID: 24410438 [Abstract] [Full Text] [Related]
18. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles. Kuo YC, Chen YC. Int J Pharm; 2015 Feb 01; 479(1):138-49. PubMed ID: 25560309 [Abstract] [Full Text] [Related]
19. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S. Nanotechnology; 2011 Nov 11; 22(45):455102. PubMed ID: 22019849 [Abstract] [Full Text] [Related]
20. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles. Wang Y, Li P, Chen L, Gao W, Zeng F, Kong LX. Drug Deliv; 2015 Feb 11; 22(2):191-8. PubMed ID: 24437926 [Abstract] [Full Text] [Related] Page: [Next] [New Search]